NPR - GLP-1 agonist drugs like Ozempic, Wegovy and Zepbound have helped many... lose weight after several cycles of gaining and shedding weight following various restrictive diets. As many stop taking it due to cost, shortages, side effects and life events, they are now confronting the realities of the drugs' limitations.
➡️ Doctors acknowledge that food and lifestyle changes may not be enough to help patients with obesity lose weight. GLP-1 agonist drugs address various hormonal and metabolic drivers of obesity.
➡️ Once a patient stops treatment for these biological factors of obesity, they may return. New analysis shows only 17% of people were able to maintain 80% of their weight loss after they stopped taking the drugs.
➡️ A person’s response to being on the drugs — or to halting them — will depend on the particulars of their biology, genetics, or hormonal makeup.
➡️ So, what should you do if you have to transition off of the drug? Obesity experts recommend creating a personalized plan with your doctor — tapering off the drugs, for example, while stepping up dietary counseling.
➡️ Once a patient stops treatment for these biological factors of obesity, they may return. New analysis shows only 17% of people were able to maintain 80% of their weight loss after they stopped taking the drugs.
➡️ A person’s response to being on the drugs — or to halting them — will depend on the particulars of their biology, genetics, or hormonal makeup.
➡️ So, what should you do if you have to transition off of the drug? Obesity experts recommend creating a personalized plan with your doctor — tapering off the drugs, for example, while stepping up dietary counseling.
No comments:
Post a Comment